GW679769 In Fibromyalgia
NCT00264628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2015-04-16
Summary
The purpose of the study is to investigate safety, tolerability and efficacy of oral GW679769 up to 120 mg dose compared to placebo in patients with ACR(American College of Rheumatology)-defined fibromyalgia, co-morbid with depression.
Conditions
- Depressive Disorder
- Depression
- Fibromyalgia
Interventions
- DRUG
-
GW679769
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
- Primary Completion
- 2006-09-30
- Completion
- 2006-09-30
More Related Trials
-
A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.
NCT00612170 ·Status: COMPLETED ·Phase: PHASE3
-
Living With Fibromyalgia: Triggers,Subgroups, and a Cognitive-Behavioral and Interactive Technology-Based Intervention
NCT00222690 ·Status: COMPLETED
-
A Study of Duloxetine in Fibromyalgia
NCT01552057 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Pain Associated With Fibromyalgia
NCT02187159 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Versus Placebo in the Treatment of FMS
NCT00233025 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Pregabalin Combined With Desvenlafaxine in Patients With Fibromyalgia
NCT07171320 ·Status: RECRUITING ·Phase: NA
-
A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia
NCT00673452 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Pregabalin Combined With Toludesvenlafaxine in Patients With Fibromyalgia
NCT07208357 ·Status: RECRUITING ·Phase: NA
-
Agomelatine in Depressed Patients With Fibromyalgia
NCT01731899 ·Status: COMPLETED
-
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
NCT03783910 ·Status: COMPLETED ·Phase: PHASE2
-
Gabapentin in Fibromyalgia Trial (GIFT)
NCT00057278 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia
NCT00696787 ·Status: TERMINATED ·Phase: PHASE2
-
Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement
NCT05718908 ·Status: COMPLETED
-
Repetitive Trans-cranial Magnetic Stimulation of the Motor Cortex in Fibromyalgia: A Study Evaluating the Clinical Efficiency and the Metabolic Correlate in 18FDG-PET
NCT00697398 ·Status: COMPLETED ·Phase: NA
-
A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia
NCT00357825 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome
NCT00190866 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
NCT03056690 ·Status: COMPLETED ·Phase: PHASE2
-
Internet-based Exposure-based Therapy for Fibromyalgia: A Randomized Controlled Trial.
NCT02638636 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia
NCT00116129 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia
NCT00607256 ·Status: TERMINATED ·Phase: PHASE3
-
Suvorexant in Insomnia Co-morbid With Fibromyalgia
NCT02684136 ·Status: TERMINATED ·Phase: PHASE4
-
Duloxetine Metabolism and Fibromyalgia
NCT06866444 ·Status: RECRUITING
-
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
NCT01271933 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia
NCT00313885 ·Status: COMPLETED ·Phase: PHASE2
-
Trigeminal Nerve Stimulation (TNS) in the Treatment of Fibromyalgia
NCT02120690 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2